Active Pharmaceutical Ingredients


At AntalGenics we develop novel therapeutic leads, mainly for the treatment of psoriatic pruritus and psoriatic comorbidities, such as arthritis


Our R&D programme is focused on the discovery and development of new molecules to treat chronic painful disorders. Our scientific team has a long-track experience in pain research. With this knowledge, we are currently developing two new molecular entities to provide precise innovative therapies for psoriatic pruritus and osteoarthritic pain


Proven-track record in pain research
Specialists in ion channel research and neuronal exocytosis
Full access to University infrastructures
Skilled team in sensory biology
Rich-network of partner research groups
Experts in molecular modeling and in silico screening
A long standing experience in cosmeceutics

Now that you are here, take a look at our cosmetic ingredients